A detailed history of Fil LTD transactions in Profound Medical Corp. stock. As of the latest transaction made, Fil LTD holds 1,505,000 shares of PROF stock, worth $11.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,505,000
Previous 1,350,635 11.43%
Holding current value
$11.2 Million
Previous $11.5 Million 9.6%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.25 - $9.07 $1.12 Million - $1.4 Million
154,365 Added 11.43%
1,505,000 $12.6 Million
Q1 2024

May 13, 2024

BUY
$7.3 - $9.46 $1.1 Million - $1.42 Million
150,000 Added 12.49%
1,350,635 $11.5 Million
Q2 2023

Aug 11, 2023

BUY
$9.27 - $14.88 $120,602 - $193,588
13,010 Added 1.1%
1,200,635 $15.6 Million
Q1 2023

May 11, 2023

SELL
$8.85 - $13.27 $336,742 - $504,923
-38,050 Reduced 3.1%
1,187,625 $11 Million
Q4 2022

Feb 13, 2023

BUY
$3.18 - $10.91 $382,522 - $1.31 Million
120,290 Added 10.88%
1,225,675 $13.3 Million
Q3 2022

Nov 10, 2022

BUY
$3.99 - $9.3 $59,850 - $139,500
15,000 Added 1.38%
1,105,385 $4.47 Million
Q2 2022

Aug 12, 2022

BUY
$6.34 - $9.53 $158,563 - $238,345
25,010 Added 2.35%
1,090,385 $7.96 Million
Q1 2022

May 13, 2022

BUY
$8.16 - $11.33 $326,400 - $453,200
40,000 Added 3.9%
1,065,375 $9.59 Million
Q4 2021

Feb 14, 2022

BUY
$10.38 - $15.2 $259,500 - $380,000
25,000 Added 2.5%
1,025,375 $11.6 Million
Q3 2021

Nov 15, 2021

BUY
$13.6 - $17.88 $1.7 Million - $2.24 Million
125,030 Added 14.28%
1,000,375 $14.6 Million
Q2 2021

Aug 13, 2021

BUY
$16.0 - $20.59 $800,160 - $1.03 Million
50,010 Added 6.06%
875,345 $14.3 Million
Q1 2021

May 14, 2021

SELL
$19.16 - $28.09 $3.83 Million - $5.62 Million
-200,025 Reduced 19.51%
825,335 $16.6 Million
Q4 2020

Feb 08, 2021

SELL
$16.4 - $22.9 $1.64 Million - $2.29 Million
-100,010 Reduced 8.89%
1,025,360 $21.1 Million
Q3 2020

Nov 13, 2020

BUY
$14.05 - $18.13 $3.23 Million - $4.17 Million
229,950 Added 25.68%
1,125,370 $19.8 Million
Q2 2020

Aug 13, 2020

BUY
$9.41 - $16.94 $282,252 - $508,115
29,995 Added 3.47%
895,420 $15.2 Million
Q1 2020

May 14, 2020

SELL
$6.88 - $19.7 $758,176 - $2.17 Million
-110,200 Reduced 11.3%
865,425 $8.33 Million
Q4 2019

Feb 07, 2020

BUY
$6.4 - $11.95 $6.24 Million - $11.7 Million
975,625 New
975,625 $11.1 Million

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $155M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.